Joe Lennerz
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Joe Lennerz
May 17, 2024, 16:25 |
Blog
Joe Lennerz: Cover Story in Cancer Cell
Joe Lennerz, Chief Scientific Officer at BostonGene, shared on LinkedIn: "Cover Story in Cancer Cell.…
Apr 15, 2024, 21:31 |
Blog
Uta Schmidt-Straßburger: Pathology innovation is not an oxymoron – it is rather magic
Uta Schmidt-Straßburger, Scientific Director at Ulm University, shared a post by Advanced Oncology on LinkedIn:…
Apr 13, 2024, 12:47 |
Societies
Advanced Oncology's podcast guest is non other than the Chief Scientific Officer of BostonGene Dr. Joe Lennerz
Advanced Oncology posted on Instagram: "Please look forward to our new podcast episode this Friday!…
Apr 12, 2024, 05:34 |
Insight
Joe Lennerz: Quickly sharing a fantastic paper on tumour infiltrating lymphocytes in triple-negative breast cancer
Joe Lennerz, Chief Scientific Officer at BostonGene, shared on LinkedIn: "Quickly sharing a fantastic paper…
Dec 12, 2023, 18:08 |
Career
Joe Lennerz was appointed as the Chief Scientific Officer at BostonGene
Quoting Joe Lennerz, Chief Scientific Officer at BostonGene, on LinkedIn: ''Some brief personal news. I've…
All:
5
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube